The regulatory file for eggshell membrane collagen
Eggshell membrane collagen is an egg-derived food ingredient, and the regulatory file turns on three points: the egg allergen declaration, the route by which the membrane hydrolysate may be sold in the destination, and the contaminant and microbiological limits for the finished product. The specification and the COA support the file; they do not decide the route. The buyer's regulatory team confirms it.
The specification describes the material; the regulatory file shows the egg allergen position, the market route and the limits that apply to the finished product.
The four checks
The first check is the ingredient route: whether the membrane hydrolysate can be sold as a food or a food supplement in the destination, and on what basis. The second is the allergen declaration, which for this material is egg. The third is the contaminant and microbiological panel against the limit for the product as sold. The fourth is the label and any claim.
Each check has a different owner: the ingredient route belongs to the supplier and the importer, the allergen declaration to the recipe and the label, the contaminant limit to the food category and the dose, and the claim to the brand. A certificate can be complete and still leave all four open.
Egg membrane is not hide collagen. It is an animal by-product with a shorter documented history of food use in some markets, so the novel-food or new-dietary-ingredient question is a real one. The answer is specific to the hydrolysate, the process and the use level.
European Union
In the EU, the route is checked against Regulation (EU) 2015/2283 on novel foods and the Union list in Implementing Regulation (EU) 2017/2470. Where an entry applies, it is tied to a defined material, a population and a maximum use level; a different membrane preparation, enzyme or peptide cut can fall outside it. The buyer's team confirms that the current text covers the exact material and use.
Food supplements sit under Directive 2002/46/EC, labelling under Regulation (EU) No 1169/2011, and claims under Regulation (EC) No 1924/2006. Contaminant limits are in Regulation (EU) 2023/915. A product can be a permitted supplement and still fail the allergen, contaminant or claim review.
Great Britain applies retained food law, while Northern Ireland follows the EU framework. The delivery address decides which applies.
United States
In the United States, the question is how the material is positioned as a dietary ingredient or a food ingredient, and whether the intended use fits that position. A new dietary ingredient needs a notification under 21 U.S.C. 350b unless it has been present in the food supply in a form in which the food has not been chemically altered. The supplier states the basis; the buyer checks that it extends to the finished product.
Dietary supplement manufacturing is covered by 21 CFR 111, and the Supplement Facts panel by 21 CFR 101.36. Egg is a major food allergen under the Food Allergen Labeling and Consumer Protection Act, so the finished label has to declare it. A structure/function statement is the brand's responsibility; no disease claim is open.
There is no federal maximum level for lead in dietary supplements. A customer specification, a state rule such as California Proposition 65, or USP <2232> may set the panel. The destination and the daily dose have to be checked together.
The contaminant and microbiological table
| Parameter | EU supplement reference | US federal position | File should show |
|---|---|---|---|
| Lead (Pb) | 3.0 mg/kg | No federal limit specific to supplements; state rules apply | Lot result, method, limit and dose calculation |
| Cadmium (Cd) | 1.0 mg/kg | No federal limit specific to supplements | Lot result and any category exception |
| Mercury (Hg) | 0.10 mg/kg | No federal limit specific to supplements | Lot result and method |
| Arsenic (As) | Not harmonised; member state rules may apply | No federal limit specific to supplements | The agreed limit and the method |
| Microbiology | Specification and customer criteria | Current good manufacturing practice | APC, yeast and mould, E. coli and Salmonella absence |
The EU figures come from Regulation (EU) 2023/915 and apply to food supplements as sold; an ingredient sold to a food manufacturer is assessed against the limit for the food category it enters. The catalogue panel matches those figures for lead, cadmium and mercury, and sets arsenic at ≤2 mg/kg; the EU has no harmonised figure for this category. Salmonella absence is the line that cannot be traded away.
Claims and label language
No disease-related claim is permitted for a food or a food supplement in the EU, the US or the UK. Protein claims are regulated separately: the EU conditions in Regulation (EC) No 1924/2006 apply to the food as sold, and US protein claims follow 21 CFR 101.54 and the serving.
In the EU, a health claim about eggshell membrane collagen would need an authorisation under Regulation (EC) No 1924/2006; as of this review no collagen-peptide health claim is authorised, so the label should stay with the nutrient content and the ingredient description. In the US, a structure/function statement is the brand's responsibility and must be substantiated. This site makes neither claim.
The egg declaration is not a claim and cannot be left off for marketing reasons. A product described as “egg-free” while it contains a membrane hydrolysate is mislabelled.
The document pack
- Batch COA with protein and its factor, peptide content, molecular weight, loss on drying, ash, heavy metals, microbiology and mesh.
- Specification and data sheet naming the membrane source, hydrolysis process and peptide distribution.
- Safety data sheet in the 16-section format.
- Egg allergen statement for the material and every carrier or processing aid.
- Hydrolysis enzyme declaration, with source and carrier.
- Origin, non-GMO, and halal or kosher statements where available.
- Novel-food or new-dietary-ingredient route statement, where required, and the microbial kill-step validation.
The allergen statement is a document, not a sentence on the COA. It should name egg and cover the finished product, including any carrier that carries egg or is handled on a shared line. The COA page lists the release tests, the identity page covers the source evidence, and the EU and US regulatory notes collect the framework references.
What to check before the first order
- Is the material named as hydrolysed eggshell membrane collagen, with source and CAS?
- Does the allergen statement cover egg, the enzyme and every carrier?
- Has the destination route been confirmed for the exact material, process and use?
- Are the contaminant results converted to the finished-product dose, including state rules?
- Is there a validated kill step and a Salmonella absence result for the lot?
- Is every label statement a nutrient claim, a documented structure/function statement or a required allergen declaration?
- Do the quotation, specification, COA and allergen statement refer to the same version?
The product page carries the catalogue specification, and the quality page describes how the release file is assembled.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation